Evidence map›Paper›PMID 25428446›Full record

Trial reportInternational journal of clinical pharmacy2015

Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.

Aleksandra Drozdowska, Tomasz Hermanowski

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of clinical pharmacy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aleksandra DrozdowskaDepartment of Pharmacoeconomics, Medical University of Warsaw, ul. Żwirki i Wigury 81, 02-091, Warsaw, Poland, o.drozdowska@gmail.com.
Tomasz Hermanowski
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenerics have the potential to contain drug therapy costs; successful implementation of generic substitution policy largely depends on consumers' willingness to choose generics.

objectiveThis study aims to analyse the opinions, experiences and preferences of Polish patients towards generic medicines.

settingThe study was performed in Poland.

methodThe survey was conducted in June 2013 by means of face-to-face interviews. Respondents were drawn from the general population according to a population structure. The study covered a representative sample of 1,000 Poles; the results can be generalized to apply to the Polish population at large.

resultsFifty-two percent of respondents declared to be more often choosing generics, twenty-three percent did not have any specific preferences, and twenty-five percent were more willing to choose brand-name medicines. Past experience with cheaper generic medicines, secondary or lower education, low income and residence in specific regions of Poland were all significantly associated with an increased willingness to choose generics. Respondents' attitudes towards generics were mostly influenced by the opinions of doctors and pharmacists. According to respondents, attitudes towards generics among doctors, pharmacists, family and friends, and in the mass media were mostly positive. There was no relationship between the preference of respondents for generics and factors such as their age, life stage, gender, household size or urban/rural locality. As a result of substituting a brand-name drug with its generic equivalent, 72 % of respondents reported that they had not noticed any difference in drug effectiveness; 21 % had experienced a reduced effectiveness of treatment or increased side effects at least once; and 7 % claimed the generic worked better. The majority of respondents who used cheaper substitutes claimed that generics represented good or very good quality.

conclusionThe study demonstrates that, when choosing medicines, Poles rely mainly on the opinions of their doctors and pharmacists. Therefore, it is recommended that: (1) the option of using generics be promoted when writing prescriptions, and (2) the obligation on pharmacists to inform customers of their option to purchase generics be enforced.

Indexed as

Health Knowledge, Attitudes, PracticePatient SatisfactionAdolescentAdultDrugs, GenericDrug SubstitutionFemaleHumansMaleMiddle AgedPatient PreferencePolandSurveys and QuestionnairesYoung AdultDrugs, Generic

Identifiers

PMID25428446
PMCPMC4312389
OpenAlexW2047070644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.